Cubist Pharmaceuticals, Inc. (NASDAQ:CBST)
CAPS Rating:
A biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment.
RSS Headlines
Fool UK
Recs
IBD pick. Good growth prospects and not too expensive compared to peers.